Walleye Trading
WVE icon

Walleye Trading’s Wave Life Sciences WVE Stock Holding History

Walleye Trading’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,900
Closed -$64.5K – 4527
2026
Q1 		$64.5K Buy
8,900
+2,200
+33% +$28.7K ﹤0.01% 3611
2025
Q4 		$114K Sell
6,700
-9,200
-58% -$93.5K ﹤0.01% 3678
2025
Q3 		$116K Buy
+15,900
New +$129K ﹤0.01% 3649
2022
Q1 		– Sell
-6,800
Closed -$21K – 5972
2021
Q4 		$21K Buy
+6,800
New +$28.2K ﹤0.01% 4921
2021
Q1 		– Sell
-12,800
Closed -$101K – 5374
2020
Q4 		$101K Buy
+12,800
New +$107K ﹤0.01% 3929
2020
Q3 		– Sell
-59,400
Closed -$618K – 4688
2020
Q2 		$618K Sell
59,400
-13,100
-18% -$123K ﹤0.01% 2086
2020
Q1 		$679K Buy
+72,500
New +$618K 0.01% 1612
2019
Q3 		– Sell
-5,700
Closed -$149K – 4492
2019
Q2 		$149K Buy
+5,700
New +$160K ﹤0.01% 3129

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GP
GSK plc London $602M AUM
MC
Maverick Capital Dallas, Texas $11.3B AUM 76.6% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
RAM
Readystate Asset Management Chicago, Illinois $2.93B AUM 18.57% 1-Year Est. Return

Walleye Trading's WVE Position: Q2 2026 in Review

Walleye Trading sold out of Wave Life Sciences (WVE) in Q2 2026, closing a stake of 16,288 shares — an estimated $118K sold.

Walleye Trading first reported a position in WVE in Q4 2020 and held it in 5 quarters. The position peaked at $565K in Q4 2025. 239 funds tracked by Wall St. Rank hold WVE as of Q2 2026.

  • Walleye Trading reported no remaining Wave Life Sciences position as of Q2 2026 after selling out during the quarter.
  • Walleye Trading sold 16,288 Wave Life Sciences shares in Q2 2026, an estimated $118K.
  • Walleye Trading first reported a position in Wave Life Sciences in Q4 2020 and held it in 5 quarters.
  • Walleye Trading's Wave Life Sciences position peaked at $565K in Q4 2025.
  • 239 funds tracked by Wall St. Rank held Wave Life Sciences as of Q2 2026.

Based on Walleye Trading's 13F filing for Q2 2026, filed 3 Aug 2026.